Professor Patrick Mark involved in a study

Image of Patrick Mark

Professor Patrick Mark was recently involved in a study demonstrating that dialysis patients have suboptimal responses to COVID-19 vaccination. They appear to be particularly vulnerable to the Delta variant, making the recent introduction of booster vaccines for the ‘clinically extremely vulnerable’ an extremely welcome development. The study was published in the Lancet. Carr, E. J. et al. (2021) Neutralising antibodies after COVID-19 vaccination in UK haemodialysis patients. Lancet, (doi: 10.1016/S0140-6736(21)01854-7)' Read the study here: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)01854-7/fulltext?fbclid=IwAR06u0GxyvMzHVVhoQ3lPbSQQGteiXImPYHm844-5_PTKS5huLXN6bpJWfM

 

 


First published: 25 October 2021

<< News